Epiduo and Remicade drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Epiduo (adapalene; benzoyl peroxide) and Remicade (infliximab). Common drug interactions include eczema herpeticum among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people have when they take Epiduo and Remicade. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Epiduo?

Epiduo has active ingredients of adapalene; benzoyl peroxide. It is often used in acne. eHealthMe is studying from 1,581 Epiduo users. Check the latest studies of Epiduo.

What is Remicade?

Remicade has active ingredients of infliximab. It is often used in crohn's disease. eHealthMe is studying from 224,011 Remicade users. Check the latest studies of Remicade.



On Jul, 14, 2026

11 people who take Epiduo and Remicade together, and have interactions are studied.

Epiduo and Remicade drug interactions.

What are the common drug interactions of Epiduo and Remicade, by gender? *:

female:

  1. Eczema herpeticum (feverish condition and widespread eruption of vesicles)
  2. Arthralgia (joint pain)
  3. Glomerulonephritis rapidly progressive (a syndrome of the kidney that is characterized by a rapid loss of renal function)
  4. Migraine (headache)
  5. Myalgia (muscle pain)
  6. Pyrexia (fever)
  7. Rosacea (a skin condition that causes facial redness)
  8. Vascular rupture

male:

  1. Abdominal pain

What are the common drug interactions of Epiduo and Remicade, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Abdominal pain

20-29:

  1. Eczema herpeticum (feverish condition and widespread eruption of vesicles)
  2. Glomerulonephritis rapidly progressive (a syndrome of the kidney that is characterized by a rapid loss of renal function)

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

  1. Inflammatory Bowel Disease: 5 people, 45.45%

* Approximation only. Some reports may have incomplete information.

Do you take Epiduo and Remicade?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Epiduo and Remicade:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Epiduo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Remicade:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Epiduo and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Remicade and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on adapalene; benzoyl peroxide and infliximab (the active ingredients of Epiduo and Remicade, respectively), and Epiduo and Remicade (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: